Bausch Health Companies Inc. (BHC) FY2026 YTD Q2 P&L / Income Statement

Bausch Health Companies Inc. (BHC) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue and costs use their disclosed categories.

Revenues

5,376,000,000 US dollars

Cost of revenue (calculated)

1,510,000,000 US dollars

Gross profit (calculated)

3,866,000,000 US dollars

Operating expenses (calculated)

4,076,000,000 US dollars

Operating income (loss)

negative 210,000,000 US dollars

Other income (expense), net (calculated)

negative 796,000,000 US dollars

Income (loss) before income taxes

negative 1,006,000,000 US dollars

Provision for income taxes

165,000,000 US dollars

Net income (loss)

negative 1,171,000,000 US dollars

Product sales revenue

5,325,000,000 US dollars

Other revenues revenue

51,000,000 US dollars

Product sales cost of revenue

1,474,000,000 US dollars

Other revenues cost of revenue

36,000,000 US dollars

Selling, general and administrative

1,768,000,000 US dollars

Research and development

336,000,000 US dollars

Amortization of intangible assets

466,000,000 US dollars

Goodwill impairments

1,426,000,000 US dollars

Restructuring, integration and separation costs

22,000,000 US dollars

Other expense (income), net

58,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to Bausch Health Companies Inc.: −$1.17 B; to noncontrolling interests: −$6.00 M.